Islamic Republic of Iran

 

Sub-programme 2 Studies and Analysis

 

Women Drug Users in the Labour Market

The current report focuses on "Women Drug Users in the Labour Market",which was developed in 2012 by UNODC Iran in cooperation with the Drug Control Headquarters of Iran, with the financial support of the Kingdom of Norway under Sub-programme 2 of the Country Programme "Drug Demand Reduction and HIV Control". The study was focused on reviewing the employment situation of women drug users in Tehran. [Full Text - Fa]

 

 

 

Needs Assessment & Round Table on Access of Drug Users to HIV Prevention and Treatment Services

A "Needs Assessment on Access of Drug Users to HIV prevention and treatment services" was conducted in 2011 by UNODC Iran under the Country Programme 2011-2014. The purpose of this study was to review the gaps in the provision of HIV prevention and treatment services to Injecting Drug Users (IDUs). These gaps were identified through interviews with service providers, experts and drug users. [Full Text - Fa]

UNODC Iran organized a follow-up round table on the access of Drug Users to HIV prevention and treatment services in July 2012, with the purpose of collecting the views of Iranian authorities, experts and NGOs on the aforementioned issue. All the views were compiled to form the report of the round table. [Full Report - Fa]

 

Bio-behavioural Surveillance Study among Injecting Drug Users (IDUs) and their Sexual Partners

A Bio-behavioural Surveillance Study among Injecting Drug Users (IDUs) and their Sexual Partners was conducted by UNODC Iran under the Country Programme 2011-2014. It was carried out in the three cities of Karaj, Isfahan and Gorgan in 2011-2012, over the period of approximately 12 months. The purpose of this study was to assess, inter alia, the prevalence of HIV among IDUs and their sexual partners, as well as their knowledge on HIV, risky behaviours, and drug-use history. [Full Text-Fa]

 

The Need for Gender-Responsive Programs - A Qualitative Study

The objective of the study is to provide criteria of good gender-responsive social support programmes for women drug users. The present study was carried out under the project IRNK13 - "Promotion of HIV/AIDS Prevention and Care Programmes for Female Injecting Drug Users in I. R. of Iran" with the financial support of the Swiss Government. [Full Text-En]

 

Study: Anti-retroviral Therapy (ART)

This study, titled "Impact of Drug Use on the Coverage of Anti Retroviral Therapy (ART) and the Rate of Treatment Retention among Medical Universities' Behavioral Diseases Counseling Centers' Clients " has been conducted by UNODC under UNAIDS Program Acceleration Fund (PAF) in 2007. The purpose of this study is to review the situation of ART in the country with a focus on drug users. Furthermore, the rate of treatment retention, drop-outs, and the impact of current and previous drug abuse on the process of ART have been studied. [Full Text-Fa]

Characteristics of Drug Users Referring to State Welfare Organization (SWO) Drug Treatment Centres

The research was conducted under the Project E52 in 2004 by Dr. Hooman Narenjiha in cooperation with the State Welfare Organization under the title of "Profile of drug users referring to SWO drug treatment centres during 1998-2002". Profile of around 130,000 drug users who have referred to 80 treatment centres of SWO in the country are studied in this research. Besides examining drug users' profile which was the main purpose of the research, other data such as drug type, drug use pattern and their injection practices are studied as well. [Full Text - Fa]

تعیین خصوصیات فردی معتادان مراجعه کننده به مراکز درمان و بازتوانی سر پایی معتادان ، وابسته به سازمان بهزیستی کشور

این تحقیق تحت عنوان "تعیین خصوصیات فردی معتادان مراجعه کننده به مراکز درمان و بازتوانی سرپایی مصرف¬کنندگان مواد، وابسته به سازمان بهزیستی کشور طی سالهای 1377-1381"در سال 1383 توسط آقای دکتر هومان نارنجی¬ها و با همکاری سازمان بهزیستی کشور و تحت پروژه E52 دفتر مقابله با مواد مخدر و جرم سازمان ملل متحد در ایران انجام گرفت. خصوصیات 130000 نفر از مراجعین به 80 مرکز درمانی تحت پوشش سازمان بهزیستی کل کشور در این پژوهش بررسی شدند. علاوه بر هدف کلی این مطالعه که بررسی خصوصیات فردی مصرف¬کنندگان بود، سایر اطلاعات همانند نوع ماده مصرفی، الگوی مصرف و سابقه تزریق آنها مورد بررسی قرار گرفت. [Full Text - Fa]

Methadone Maintenance Treatment (MMT) for Drug-using Prisoners in Ghezel Hesar Prison

The research is conducted by a research team headed by Saman Zamani, PhD; UNAIDS Collaborating Centre on Socio-epidemiological HIV Research, Department of Global Health and Socio-epidemiology, Kyoto University School of Public Health, in 2008 under the title of "Methadone Maintenance Treatment (MMT) for Drug-Using Prisoners in Ghezel Hesar Prison, Karaj, Iran". This research describes measures on MMT and explores the experiences and attitudes of MMT users and services providers in Ghezel Hesar Prison and barriers against the provision and further scaling up of MMT in the said prison. The aim of the study was to acquire overall insight into the MMT practice in the prison. The study was designed and implemented by using field observations, focus group discussions and individual interviews with participation of overall, 30 prisoners and 15 prison staff and health policy makers. The study was supported by the UNODC, Office for I.R. of Iran. [Full Text - En]

درمان نگاهدارنده با متادون ( MMT) برای زندانیان مصرف­کننده مواد در زندان قزل­ حصار

این تحقیق با عنوان "درمان نگهدارنده با متادون برای زندانیان قزل­حصار کرج، ایران" در سال1387 توسط یک تیم به سرپرستی دکتر سامان زمانی، از مرکز همکاری­ تحقیقات اجتماعی-شیوع­شناسی اچ­آی­وی برنامه مشترك سازمان ملل متحد در زمينه ايدز (UNAIDS)، دپارتمان سلامت جهانی و شیوع­شناسی- اجتماعی، دانشکده بهداشت کیوتو و با حمایت دفتر مقابله با مواد و جرم مخدر سازمان ملل متحد در ایران انجام شد. در این تحقیق درمان نگاهدارنده با متادون توصیف شده و تجارب و نگرش مراجعان و ارائه دهندگان خدمات درمان نگاهدارنده با متادون در زندان قزل­حصار و هم­چنین موانع ارائه و گسترش درمان نگاهدارنده با متادون در این زندان مورد بررسی قرار گرفته است. هدف این مطالعه حصول درک بهتری از رویه­َ عملی درمان نگاهدارنده با متادون در زندان بود. این مطالعه با مشاهدات میدانی، بحث­های گروهی متمرکز و مصاحبه های فردی با 30 زندانی و 15 نفر از کارکنان زندان و سیاست­گذاران بخش بهداشت طراحی و اجرا شد. [Full Text - En]